Sun Pharma Q3 beats estimates, net profit rises 19%; declares ₹10.50 interim dividend

Share it

EBITDA surged 25% to ₹4,192.2 crore and the EBITDA margin stood at 30.7% in the reporting quarter compared to 27.1% in the year-ago period. Shares of Sun Pharmaceutical Industries Ltd ended at ₹1,743.10, down by ₹2.15, or 0.12%, on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *